CIPLACiplaCIPLA info
$17.29info1.49%24h
Global rank1164
Market cap$13.96B
Change 7d0.85%
YTD Performance17.56%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Cipla (CIPLA) Stock Overview

    Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

    CIPLA Stock Information

    Symbol
    CIPLA
    Address
    Cipla HouseMumbai, 400013India
    Founded
    -
    Trading hours
    -
    Website
    https://www.cipla.com
    Country
    🇮🇳 India
    Phone Number
    91 22 2482 6000

    Cipla (CIPLA) Price Chart

    -
    Value:-

    Cipla Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $17.29
    N/A
    Market Cap
    $13.96B
    N/A
    Shares Outstanding
    807.36M
    N/A
    Employees
    32.32K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org